These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 35529112)
1. Dual-mode US/MRI nanoparticles delivering siRNA and Pt(iv) for ovarian cancer treatment. Zhang Y; Huang H; Fu H; Zhao M; Wu Z; Dong Y; Li H; Duan Y; Sun Y RSC Adv; 2019 Oct; 9(57):33302-33309. PubMed ID: 35529112 [TBL] [Abstract][Full Text] [Related]
2. Multifunctional tumor-targeted PLGA nanoparticles delivering Pt(IV)/siBIRC5 for US/MRI imaging and overcoming ovarian cancer resistance. Zhang Y; Dong Y; Fu H; Huang H; Wu Z; Zhao M; Yang X; Guo Q; Duan Y; Sun Y Biomaterials; 2021 Feb; 269():120478. PubMed ID: 33213862 [TBL] [Abstract][Full Text] [Related]
3. GSH-sensitive Pt(IV) prodrug-loaded phase-transitional nanoparticles with a hybrid lipid-polymer shell for precise theranostics against ovarian cancer. Huang H; Dong Y; Zhang Y; Ru D; Wu Z; Zhang J; Shen M; Duan Y; Sun Y Theranostics; 2019; 9(4):1047-1065. PubMed ID: 30867815 [No Abstract] [Full Text] [Related]
4. Zwitterionic nanoparticles constructed from bioreducible RAFT-ROP double head agent for shell shedding triggered intracellular drug delivery. Huang P; Liu J; Wang W; Zhang Y; Zhao F; Kong D; Liu J; Dong A Acta Biomater; 2016 Aug; 40():263-272. PubMed ID: 26607767 [TBL] [Abstract][Full Text] [Related]
5. Multimodal and multifunctional nanoparticles with platelet targeting ability and phase transition efficiency for the molecular imaging and thrombolysis of coronary microthrombi. Bai S; Liao J; Zhang B; Zhao M; You B; Li P; Ran H; Wang Z; Shi R; Zhang G Biomater Sci; 2020 Sep; 8(18):5047-5060. PubMed ID: 32830839 [TBL] [Abstract][Full Text] [Related]
6. Tumor-penetrating Peptide Conjugated and Doxorubicin Loaded T Gao L; Yu J; Liu Y; Zhou J; Sun L; Wang J; Zhu J; Peng H; Lu W; Yu L; Yan Z; Wang Y Theranostics; 2018; 8(1):92-108. PubMed ID: 29290795 [TBL] [Abstract][Full Text] [Related]
7. cRGD-Modified Benzimidazole-based pH-Responsive Nanoparticles for Enhanced Tumor Targeted Doxorubicin Delivery. Liu J; Liu Q; Yang C; Sun Y; Zhang Y; Huang P; Zhou J; Liu Q; Chu L; Huang F; Deng L; Dong A; Liu J ACS Appl Mater Interfaces; 2016 May; 8(17):10726-36. PubMed ID: 27058429 [TBL] [Abstract][Full Text] [Related]
8. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound. Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431 [TBL] [Abstract][Full Text] [Related]
9. Folate-targeted perfluorohexane nanoparticles carrying bismuth sulfide for use in US/CT dual-mode imaging and synergistic high-intensity focused ultrasound ablation of cervical cancer. Zhou D; Li C; He M; Ma M; Li P; Gong Y; Ran H; Wang Z; Wang Z; Zheng Y; Sun Y J Mater Chem B; 2016 Jun; 4(23):4164-4181. PubMed ID: 32264619 [TBL] [Abstract][Full Text] [Related]
10. Carboplatin-Complexed and cRGD-Conjugated Unimolecular Nanoparticles for Targeted Ovarian Cancer Therapy. Wang Y; Wang L; Chen G; Gong S Macromol Biosci; 2017 May; 17(5):. PubMed ID: 27911475 [TBL] [Abstract][Full Text] [Related]
11. Nano-assembly of ursolic acid with platinum prodrug overcomes multiple deactivation pathways in platinum-resistant ovarian cancer. Wang Y; Luo Z; Zhou D; Wang X; Chen J; Gong S; Yu Z Biomater Sci; 2021 Jun; 9(11):4110-4119. PubMed ID: 33949442 [TBL] [Abstract][Full Text] [Related]
12. Altered Cell Cycle Arrest by Multifunctional Drug-Loaded Enzymatically-Triggered Nanoparticles. Huang C; Sun Y; Shen M; Zhang X; Gao P; Duan Y ACS Appl Mater Interfaces; 2016 Jan; 8(2):1360-70. PubMed ID: 26698111 [TBL] [Abstract][Full Text] [Related]
13. Carboplatin prodrug conjugated Fe Song H; Quan F; Yu Z; Zheng M; Ma Y; Xiao H; Ding F J Mater Chem B; 2019 Jan; 7(3):433-442. PubMed ID: 32254730 [TBL] [Abstract][Full Text] [Related]
14. Design of an Amphiphilic Poly(aspartamide)-mediated Self-assembled Nanoconstruct for Long-Term Tumor Targeting and Bioimaging. Cherukula K; Uthaman S; Park IK Molecules; 2019 Mar; 24(5):. PubMed ID: 30832383 [TBL] [Abstract][Full Text] [Related]
15. cRGD-functionalized nanoparticles for combination therapy of anti-endothelium dependent vessels and anti-vasculogenic mimicry to inhibit the proliferation of ovarian cancer. Wang Y; Tong L; Wang J; Luo J; Tang J; Zhong L; Xiao Q; Niu W; Li J; Zhu J; Chen H; Li X; Wang Y Acta Biomater; 2019 Aug; 94():495-504. PubMed ID: 31252171 [TBL] [Abstract][Full Text] [Related]
16. US/MR Bimodal Imaging-Guided Bio-Targeting Synergistic Agent for Tumor Therapy. Jiang F; Wang L; Tang Y; Wang Y; Li N; Wang D; Zhang Z; Lin L; Du Y; Ou X; Zou J Int J Nanomedicine; 2022; 17():2943-2960. PubMed ID: 35814614 [TBL] [Abstract][Full Text] [Related]
17. Porous Au@Pt Nanoparticles: Therapeutic Platform for Tumor Chemo-Photothermal Co-Therapy and Alleviating Doxorubicin-Induced Oxidative Damage. Yang Q; Peng J; Xiao Y; Li W; Tan L; Xu X; Qian Z ACS Appl Mater Interfaces; 2018 Jan; 10(1):150-164. PubMed ID: 29251910 [TBL] [Abstract][Full Text] [Related]
18. Sialic acid-engineered mesoporous polydopamine nanoparticles loaded with SPIO and Fe Shu G; Chen M; Song J; Xu X; Lu C; Du Y; Xu M; Zhao Z; Zhu M; Fan K; Fan X; Fang S; Tang B; Dai Y; Du Y; Ji J Bioact Mater; 2021 May; 6(5):1423-1435. PubMed ID: 33210034 [TBL] [Abstract][Full Text] [Related]
19. Tumor microenvironment targeting with dual stimuli-responsive nanoparticles based on small heat shock proteins for antitumor drug delivery. Shi K; Wang Y; Zhou X; Gui H; Xu N; Wu S; He C; Zhao Z Acta Biomater; 2020 Sep; 114():369-383. PubMed ID: 32688090 [TBL] [Abstract][Full Text] [Related]
20. Multifunctional Theranostic Nanoparticles for Enhanced Tumor Targeted Imaging and Synergistic FUS/Chemotherapy on Murine 4T1 Breast Cancer Cell. Kang Z; Yang M; Feng X; Liao H; Zhang Z; Du Y Int J Nanomedicine; 2022; 17():2165-2187. PubMed ID: 35592098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]